Trials / Completed
CompletedNCT03511326
PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK
Subject Reported Outcomes on Satisfaction, Safety and Efficacy With Luxerm® in the Field-directed Treatment of Thin or Non-hyperkeratotic and Non-pigmented Actinic Keratosis of the Face or the Scalp
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Interventional open label prospective and multicentre study conducted in Germany in subjects with thin or non-hyperkeratotic and non-pigmented multiple AKs in one anatomical area on the face (e.g., forehead or cheek or chin), excluding nose eyelids, lips and mucosa or balding scalp, using Luxerm® DL-PDT treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methyl Aminolaevulinate 16% Cream | Subject will received one session of methyl aminolevulinate Daylight Photodynamic therapy |
Timeline
- Start date
- 2017-06-07
- Primary completion
- 2017-11-28
- Completion
- 2017-11-28
- First posted
- 2018-04-27
- Last updated
- 2021-02-18
- Results posted
- 2020-12-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03511326. Inclusion in this directory is not an endorsement.